CIK 0001137883
- Non-accelerated filer
- Smaller reporting company
BRAINSTORM CELL THERAPEUTICS INC.
Sign in to watch- Ticker
- BCLI
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 207273918
- Phone
- +1 201-488-0460
- Business address
- 1325 AVENUE OF AMERICAS, 28TH FLOOR, NEW YORK, NY, 10019
- Former names
- BRAINSTORM CELL THERAPEUTICS INC, GOLDEN HAND RESOURCES INC, WIZBANG TECHNOLOGIES INC
- 4 Derivatives Options or other derivatives
- 4 Grant or award EVP & Chief Business Officer acquired 5,543 shares (grant or award)
- 4 Grant or award COO and Chief Medical Officer acquired 35,885 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 3,012 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 8,666 shares (grant or award)
- 4 Grant or award Director acquired 8,666 shares (grant or award)
- 4 Open-market sale Director sold 10,800 shares at $2.71 ($29,268)
- 4 Open-market sale Director sold 5,000 shares at $2.57 ($12,850)
- 4 Open-market sale Director sold 41,742 shares at an average $2.60 ($108,721)
- 4 Open-market sale Director sold 10,800 shares at an average $2.64 ($28,473)
- 4 Open-market sale Director sold 13,480 shares at an average $2.73 ($36,857)
Page 8 of 17 · 329 filings